Skip to main content

Table 1 Patient participant data to be collected during the study

From: Implementation of the Goal-directed Medication review Electronic Decision Support System (G-MEDSS)© into home medicines review: a protocol for a cluster-randomised clinical trial in older adults

 

Measure (s)

Baselinea

3-months

Demographics

 Age

 

 

 Sex

 

 

 Ethnicity

 

 

 Marital Status

 

 

 Education Status

 

 

 Geographic remoteness/locality

PhARIA

 

Medication Profile

 Current medication list (prescribed, OTC and complementary, regular or PRN)

 

 

 Changes to medication list (e.g. additions, cessations, ↑↓dose)

  

 Ceased medications

 

 Adherence

MGL

 Attitudes towards deprescribingb

rPATD, rPATDCog

 

 Anticholinergic and sedative burden

DBI

Comorbidity and Physical Function

 Comorbidities

FCI

 Cognition

Mini-Cog© [46]

 Independent activities of daily living

NHCCSFSI

 Physical Function

SPPB

 Falls History

 

Others

 Institutionalisation (e.g. hospitalisation)

 

 Physician visits (e.g. GP or specialist appointments)

  

 Mortality

  

 Goals of careb

 

 
  1. aat the time of the HMR interview; bonly for patients in the intervention arm of the study
  2. PhARIA The Pharmacy Access/Remoteness Index of Australia – quantifies degree of remoteness (geographic and professional) [47], OTC Over-the-counter, PRN when required, MGL Morisky, Green, Levine Scale [48], rPATD revised Patients’ Attitudes Towards Deprescribing [34], rPATDCog Revised Patients’ Attitudes Towards Deprescribing for people with Cognitive impairment [35], DBI Drug Burden Index [28], FCI Functional Comorbidities Index [49], NHCCSFSI National Home and Community Care Services Functional Screening Instrument [50], SPPB Short Physical Performance Battery [51], GP General practitioner
  3. ↑↓ = changes